Azepexole

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H15N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DGB112538O, chemically known as 4h-oxazolo(4,5-d)azepin-2-amine, 6-ethyl-5,6,7,8-tetrahydro-, dihydrochloride but generally known as azepexole, which bears US NIH Compound Identifier 2277. Azepexole most often comes in base and hydrochloride forms. European Medicines Agency schedules Azepexole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05651MIG. The term AZEPEXOLE is an International Non-Proprietary Name. AZEPEXOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azepexole under HS 29349990 and SITC 51579. As of Q4 2014, AZEPEXOLE remains the US FDA Preferred Term for this commodity. Azepexole bears US NLM identifiers UMLS ID C0104808 and NCI Concept Code C72919. SMILES: O1C2CCN(CCC2NC1N)CC.